Digital Art Therapy for Young Cancer Survivors

NCT ID: NCT06789666

Last Updated: 2025-09-16

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 15 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-04-07
• Study Completion Date: 2027-04-30

Brief Summary

This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art therapy program. Subjects will participate in weekly art therapy prompts guided by the app and will complete weekly mental health quality of life (MHQoL) surveys during the intervention. In addition, baseline and end-of-intervention patient-reported outcome measures (PROMIS-DSF8a) and an acceptability survey will be administered. The hypothesis is that digital art therapy is feasible for young adult cancer survivors with self-reported mood issues and is an acceptable means of administering art therapy in the patient population.

Detailed Description

The ARTCan application has been designed to define therapy strategies for the care of patients; it emerges from a unique collaboration in the disciplines of design, art, art therapy, and medicine from the College of Design, Architecture, Art, and Planning (DAAP) at the University of Cincinnati (UC) and the School of Medicine, the University of North Carolina, Chapel Hill. The relevance of the application design was to enable the trans-disciplinary team to experiment with proof of the following concepts: 1) technology-based tools and feasibility studies for new lines of research in treatment; 2) research that embraces intellectual diversity by merging the creative disciplines; and 3) addressing issues of health and well-being of patients. This study is testing whether the digital art therapy application "Art Therapy Can Do" (ARTCan) is a feasible means of administering art therapy to young cancer survivors. The study is funded by the Ian's Friends Foundation and the Weatherspoon Foundation.

Conditions

Cancer; Pediatric Cancer; Pediatric Malignancies; Pediatric Sarcoma of Soft Tissue; Adolescent and Young Adult With Brain Cancer

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Digital Art Therapy

All participants will receive art therapy via the ARTCan App for 6 weeks, and will also be prompted to complete mental health quality of life surveys at baseline and each week, which will be available for the therapist to review.

Group Type: EXPERIMENTAL

ARTCan App

Intervention Type: BEHAVIORAL

The ARTCan App is an art therapy technology application program. The application can be accessed via the web (via computer, phone, or on a device such as an iPad). With the use of the application, participants complete weekly sessions that culminate in an "art" piece. Note that participants are not required to have expertise in drawing; developing art skills or assessing the quality of art pieces is not the focus of the ARTCan program.

Subjects will upload a photo of the art they created to this application to show proof of completion of art therapy. They will also answer questions specific to the art therapy theme for the week.

Interventions

ARTCan App

The ARTCan App is an art therapy technology application program. The application can be accessed via the web (via computer, phone, or on a device such as an iPad). With the use of the application, participants complete weekly sessions that culminate in an "art" piece. Note that participants are not required to have expertise in drawing; developing art skills or assessing the quality of art pieces is not the focus of the ARTCan program.

Subjects will upload a photo of the art they created to this application to show proof of completion of art therapy. They will also answer questions specific to the art therapy theme for the week.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

• Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
• Subject is willing and able to comply with study procedures based on the judgment of the investigator.
• Age 18-25 years at the time of consent.
• Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
• Reliable internet connection and access to a computer, smartphone, or iPad to support application and virtual study visits.
• Answers "yes" to the question "Do you experience mood issues (yes or no)?".

Exclusion Criteria

• Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).
• Subjects who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).
• Subjects unable to provide consent.
• Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 25 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ian's Friends Foundation

UNKNOWN

Sponsor Role: collaborator

UNC Lineberger Comprehensive Cancer Center

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Soma Sengupta, MD

Role: PRINCIPAL_INVESTIGATOR

UNC Lineberger Comprehensive Cancer Center

Locations

Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Devin McCarthy

Role: CONTACT

devin_mccarthy@med.unc.edu

919-445-4208

Patricia Brock

Role: CONTACT

patriciabrock@med.unc.edu

919-962-8491

Facility Contacts

Devine McCarthy

Role: primary

devin_mccarthy@med.unc.edu

919-445-4208

Patricia Brock

Role: backup

patricia_brock@med.unc.edu

+1 919-962-8491

Related Links

http://unclineberger.org/patientcare/clinical-trials/clinical-trials

Clinical trials at UNC Lineberger

Other Identifiers

LCCC2339

Identifier Type: -

Identifier Source: org_study_id